Mark H. Ravich

Board Director

Director

Rockwell Medical, Inc.Orchids Paper Products CO /DE

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 1 saleDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€23k

Latest filing published 21 May 2025 for Rockwell Medical, INC.. Read the official filing

Filing timeline

BuySale

Mark H. Ravich

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Mark H. Ravich: trading record in brief

Mark H. Ravich is a declared insider at 2 companies (board member); the most frequent names are Rockwell Medical, Inc. and Orchids Paper Products CO /DE. In total, 9 filings cover trades dated from 24 November 2015 to 20 May 2025.

Sales make up the whole of the open-market record (1 sale, €23k). Besides market trades, the filings include 5 share grants.

On 21 May 2025 came the latest disclosure, a share grant in Rockwell Medical, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.